Alexandria Real Estate Equities, Inc. Reports 4Q25 and 2025 Net Loss per Share - Diluted of $6.35 and $8.44, respectively; and 4Q25 and 2025 FFO per Share - Diluted, as Adjusted, of $2.16 and $9.01, r Jan 26, 2026 04:10PM
Alexandria Real Estate Equities, Inc. Celebrates 32 Years of Pioneering Leadership in Life Science Real Estate and Consequential Impact on Advancing Human Health Jan 5, 2026 08:30AM
Alexandria Real Estate Equities, Inc. Reports: 3Q25 and YTD 3Q25 Net Loss per Share - Diluted of $(1.38) and $(2.09), respectively; and 3Q25 and YTD 3Q25 FFO per Share - Diluted, as Adjusted, of $2.22 Oct 27, 2025 04:10PM
Alexandria Real Estate Equities, Inc./Alexandria Venture Investments Receives 2025 Charles A. Sanders, MD, Partnership Award From the Foundation for the National Institutes of Health Oct 22, 2025 08:30AM
Alexandria Real Estate opens Lilly Gateway Labs site in San Diego Sep 26, 2025 08:31AM
View Older Stories

Sep 26, 2025 08:30AM Alexandria Real Estate Equities, Inc. Strategically Partners With Lilly on Newest Lilly Gateway Labs at the One Alexandria Square Megacampus in San Diego's Torrey Pines to Accelerate the Development o
Sep 4, 2025 08:30AM Alexandria Real Estate Equities, Inc. Named One of the World's Most Trustworthy Companies by Newsweek for the Second Consecutive Year
Jul 21, 2025 04:10PM Alexandria Real Estate Equities, Inc. Reports: 2Q25 and 1H25 Net Loss per Share - Diluted of $(0.64) and $(0.71), respectively; and 2Q25 and 1H25 FFO per Share - Diluted, as Adjusted, of $2.33 and $4.
Jul 17, 2025 08:30AM Alexandria Real Estate Equities, Inc. Wins Its First International TOBY (The Outstanding Building of the Year) Award in Life Science Category for 8 Davis Drive Anchoring the Alexandria Center for Adva
Jul 17, 2025 08:30AM Alexandria Real Estate Equities, Inc. Wins Its First International TOBY (The Outstanding Building of the Year) Award in Life Science Category for 8 Davis Drive Anchoring the Alexandria Center for Adva
May 27, 2025 08:30AM Alexandria Real Estate Equities, Inc.'s Consequential Efforts to Address the Mission-Critical Need for Multifaceted Solutions to the Nation's Complex Mental Health Crisis
Apr 28, 2025 04:10PM Alexandria Real Estate Equities, Inc. Reports: 1Q25 Net Loss per Share - Diluted of $(0.07); and 1Q25 FFO per Share - Diluted, as Adjusted, of $2.30
Apr 3, 2025 08:30AM Alexandria Real Estate Equities, Inc. Named One of the Most Trustworthy Companies in America by Newsweek for Third Consecutive Year
Jan 27, 2025 04:10PM Alexandria Real Estate Equities, Inc. Reports: 4Q24 and 2024 Net (Loss) Income per Share - Diluted of $(0.38) and $1.80, respectively; 4Q24 and 2024 FFO per Share - Diluted, as Adjusted, of $2.39 and
Nov 6, 2024 08:30AM Alexandria Real Estate Equities, Inc. Enables the Discovery, Development and Delivery of New Innovative Medicines That Are Key to Addressing Significant Unmet Medical Need
Oct 21, 2024 04:10PM Alexandria Real Estate Equities, Inc. Reports: 3Q24 and YTD 3Q24 Net Income per Share - Diluted of $0.96 and $2.18, respectively; and 3Q24 and YTD 3Q24 FFO per Share - Diluted, as Adjusted, of $2.37 a
Sep 30, 2024 08:30AM Alexandria Real Estate Equities, Inc. Named One of the World's Most Trustworthy Companies by Newsweek
Sep 12, 2024 08:30AM Alexandria Real Estate Equities, Inc. Honored for Sustainable Design in Nareit's Inaugural Sustainability Impact Awards, Highlighting Its Longstanding Operational Excellence at the Vanguard and Heart
Sep 10, 2024 08:30AM Alexandria Real Estate Equities, Inc. Executive Chairman and Founder Joel S. Marcus to Be Honored With the Inaugural Bisnow Life Sciences Icon & Influencer Award
Jul 22, 2024 04:10PM Alexandria Real Estate Equities, Inc. Reports: 2Q24 and 1H24 Net Income per Share - Diluted of $0.25 and $1.22, respectively; and 2Q24 and 1H24 FFO per Share - Diluted, as Adjusted, of $2.36 and $4.71
Jun 28, 2024 04:10PM Alexandria Real Estate Equities, Inc. Releases 2023 Corporate Responsibility Report Highlighting Its Longstanding Leadership at the Vanguard and Heart of the Life Science Industry
Jun 25, 2024 08:30AM Alexandria Real Estate Equities, Inc. Announces Long-Term 127,382 RSF Lease With Top 20 Pharmaceutical Company and Longstanding Credit Tenant for New R&D Life Science Center at the SD Tech by Alex
May 6, 2024 08:30AM Alexandria Real Estate Equities, Inc. Drives Forward Its Action- and Solutions-Oriented Corporate Responsibility Initiatives Aimed at Prioritizing the Staggering Mental Health Crisis During Mental Hea
Apr 22, 2024 04:10PM Alexandria Real Estate Equities, Inc. Reports: 1Q24 Net Income per Share - Diluted of $0.97; and 1Q24 FFO per Share - Diluted, as Adjusted, of $2.35
Apr 2, 2024 08:30AM Alexandria Real Estate Equities, Inc. Named One of the Most Trustworthy Companies in America by Newsweek for Second Consecutive Year
Feb 27, 2024 07:00AM Alexandria Real Estate Equities, Inc. Continues Its Distinctive, Steadfast and Positive Impact on the Widespread and Complex Mental Health Crisis
Feb 13, 2024 05:01PM Form SC 13G/A ALEXANDRIA REAL ESTATE Filed by: VANGUARD GROUP INC
Feb 12, 2024 08:30AM Alexandria Real Estate Equities, Inc. Announces Long-Term Tenant AstraZeneca Is Investing $300 Million in a Next-Generation Cell Therapy Manufacturing Facility at the Alexandria Center for Life Scienc
Jan 29, 2024 04:10PM Alexandria Real Estate Equities, Inc. Reports: 4Q23 Net Loss per Share - Diluted of $0.54; 2023 Net Income per Share - Diluted of $0.54; and 4Q23 and 2023 FFO per Share - Diluted, As Adjusted, of $2.2
Jan 5, 2024 08:30AM Alexandria Real Estate Equities, Inc. Celebrates 30 Years at the Vanguard and Heart of the $5 Trillion Secularly Growing Life Science Industry
Oct 23, 2023 04:10PM Alexandria Real Estate Equities, Inc. Reports: 3Q23 and YTD 3Q23 Net Income per Share - Diluted of $0.13 and $1.08, respectively; and 3Q23 and YTD 3Q23 FFO per Share - Diluted, As Adjusted, of $2.26 a
Aug 16, 2023 08:30AM Alexandria Real Estate Equities, Inc. Accelerates Commitment to Advancing the Development of Novel, Safe and Effective Psychiatric Medicines to Address the Devastating and Pervasive Mental Health Cris
Jul 24, 2023 04:10PM Alexandria Real Estate Equities, Inc. Reports: 2Q23 and 1H23 Net Income per Share - Diluted of $0.51 and $0.95, respectively; and 2Q23 and 1H23 FFO per Share - Diluted, As Adjusted, of $2.24 and $4.43
Jun 28, 2023 08:30AM Alexandria Real Estate Equities, Inc.'s Pioneering, Foundational and Highly Amenitized Over 2 Million RSF Mega Campus in Greater Boston's Fenway Solidifies Its Dominance in the New Collaborative Life
Jun 20, 2023 08:30AM Alexandria Real Estate Equities, Inc.'s Unique, Highly Sought-After Labspace Assets in High-Barrier-to-Entry Markets Continue to Generate Strong Financial Returns
Apr 24, 2023 04:10PM Alexandria Real Estate Equities, Inc. Reports: 1Q23 Net Income per Share - Diluted of $0.44; and 1Q23 FFO per Share - Diluted, As Adjusted, of $2.19
Apr 24, 2023 08:30AM Alexandria Real Estate Equities, Inc. Named One of Most Trustworthy Companies in America by Newsweek
Feb 9, 2023 10:58AM Form SC 13G/A ALEXANDRIA REAL ESTATE Filed by: VANGUARD GROUP INC
Jan 30, 2023 04:10PM Alexandria Real Estate Equities, Inc. Reports: 4Q22 and 2022 Net Income per Share - Diluted of $0.31 and $3.18, respectively; and 4Q22 and 2022 FFO per Share - Diluted, As Adjusted, of $2.14 and $8.42
Oct 24, 2022 04:10PM Alexandria Real Estate Equities, Inc. Reports: 3Q22 and YTD 3Q22 Net Income per Share - Diluted of $2.11 and $2.88, respectively; and 3Q22 and YTD 3Q22 FFO per Share - Diluted, As Adjusted, of $2.13 a
Sep 12, 2022 04:05PM Alexandria Real Estate Equities, Inc. Recognizes Important Milestones in Its Pioneering of New York City's Commercial Life Science Cluster, the Only Early-Stage Life Science Ecosystem Among the Major
Jul 25, 2022 04:10PM Alexandria Real Estate Equities, Inc. Reports: 2Q22 and 1H22 Net Income per Share - Diluted of $1.67 and $0.74, respectively; and 2Q22 and 1H22 FFO per Share - Diluted, As Adjusted, of $2.10 and $4.15
Jun 22, 2022 07:30AM Alexandria Real Estate Equities, Inc. Celebrates the Grand Opening of Alexandria LaunchLabs at Columbia to Accelerate the Commercialization of Novel Translational Science to Meet Significant Unmet Med
May 16, 2022 08:30AM Alexandria Real Estate Equities, Inc. to Ring the NYSE Opening Bell to Celebrate Its 25th Anniversary as a New York Stock Exchange Listed REIT
Apr 25, 2022 04:10PM Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Reports: 1Q22 Net Loss per Share - Diluted of $0.96; 1Q22 FFO per Share - Diluted, As Adjusted, of $2.05
Mar 31, 2022 08:30AM Alexandria Venture Investments Recognized as One of the Top Five Most Active U.S. Investors in Agrifoodtech for Second Consecutive Year
Mar 2, 2022 08:30AM Alexandria Real Estate Equities, Inc. Announces Long-Term Lease With Bristol Myers Squibb for a New 427,000 RSF Innovative Research Hub at the Alexandria Point Mega Campus in the San Diego Cluster Mar
Feb 22, 2022 08:30AM Alexandria Real Estate Equities, Inc. Announces Long-Term 334,000 RSF, Full-Building Lease for the New Lilly Institute for Genetic Medicine at 15 Necco Street in the Seaport Innovation District in Gre
Feb 9, 2022 03:23PM Form SC 13G/A ALEXANDRIA REAL ESTATE Filed by: VANGUARD GROUP INC
Jan 31, 2022 04:10PM Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand, Reports: 4Q21 and 2021 Net Income per
Jan 10, 2022 04:13PM Alexandria Venture Investments Achieves Fifth Consecutive Annual #1 Most Active Corporate Investor in Biopharma
Nov 29, 2021 08:30AM Alexandria Venture Investments, One of the Year's Top Five Most Active U.S. Investors in Agrifoodtech, Accelerates Its Mission-Critical Investment Activity in a Sector Experiencing Tremendous Upsurge
Nov 16, 2021 08:07AM Alexandria Real Estate Equities, Inc. Is Leading the Integration of Mission-Critical R&D and Next-Gen Manufacturing for Companies in Research Triangle That Are Developing Targeted Gene and Cell
Oct 25, 2021 04:10PM Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand, Reports: 3Q21 and YTD 3Q21 Net Income
Oct 18, 2021 08:30AM Alexandria Venture Investments Maintains Recognition as #1 Most Active Early-Stage Life Science Investor
View Older Stories